Sam Eiber
Stock Analyst at BTIG
(4.06)
# 1,710
Out of 4,712 analysts
64
Total ratings
64.3%
Success rate
16.4%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterated: Buy | $103 | $75.29 | +36.80% | 14 | Sep 1, 2026 | |
| SBC SBC Medical Group Holdings | Reiterated: Buy | $8 | $4.43 | +80.59% | 3 | Aug 13, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $105 | $87.38 | +20.16% | 7 | Aug 11, 2026 | |
| APYX Apyx Medical | Reiterated: Buy | $6 | $3.05 | +96.72% | 8 | Aug 7, 2026 | |
| ICUI ICU Medical | Rated: Buy | $170 → $200 | $160.89 | +24.31% | 2 | Aug 7, 2026 | |
| EOLS Evolus | Reiterated: Buy | $13 | $8.88 | +46.40% | 13 | Aug 6, 2026 | |
| STIM Neuronetics | Initiated Coverage: Buy | $5 | $2.93 | +70.65% | 1 | Jul 20, 2026 | |
| BWAY BrainsWay | Initiated Coverage: Buy | $18 | $14.16 | +27.12% | 1 | Jul 20, 2026 | |
| INMD InMode | Rated: Hold | n/a | $14.81 | - | 10 | Jul 10, 2026 | |
| AIRS AirSculpt Technologies | Maintained: Hold | n/a | $2.71 | - | 5 | May 18, 2026 |
Establishment Labs Holdings
Sep 1, 2026
Reiterated: Buy
Price Target: $103
Current: $75.29
Upside: +36.80%
SBC Medical Group Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $4.43
Upside: +80.59%
Merit Medical Systems
Aug 11, 2026
Reiterated: Buy
Price Target: $105
Current: $87.38
Upside: +20.16%
Apyx Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $3.05
Upside: +96.72%
ICU Medical
Aug 7, 2026
Rated: Buy
Price Target: $170 → $200
Current: $160.89
Upside: +24.31%
Evolus
Aug 6, 2026
Reiterated: Buy
Price Target: $13
Current: $8.88
Upside: +46.40%
Neuronetics
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.93
Upside: +70.65%
BrainsWay
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $14.16
Upside: +27.12%
InMode
Jul 10, 2026
Rated: Hold
Price Target: n/a
Current: $14.81
Upside: -
AirSculpt Technologies
May 18, 2026
Maintained: Hold
Price Target: n/a
Current: $2.71
Upside: -